NewsRx Logo Login/Signup
Home Newsletters Products Library About Us Contact -- Search NewsRx

NewsRx | Free Trials
Advertisement
VerticalNews | Global Warming
NewsRx | Free Newsletters
 
----------
------------
NewsRx on Facebook
-----
NewsRx Passes
Press Release Submissions
PR Login
-----
2008 Award Logo
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
-----
Google 2009 PageRank: #2 Among Top Health News and Media Publications
Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information:
verify here.

Security by Verisign

Search Results for CHOP


Filter Articles: Clinical News | Consumer News | Business News | All News | More Options

Results 1 - 20      Next >


Refine Search
Display Mode: Context | Summary
Golden Green Enterprises Limited Prices $24 Million Public Equity Offering and Announces Listing on NASDAQ
2009 NOV 24 ... Golden Green Enterprises Ltd. (NASDAQ:CHOP) ("Golden Green" or the "Company"), a leading China-based specialty precision ...
Subject: Golden Green Enterprises Limited
Price: $3.00
*
H.E.A.T. Honors Contributions To Auto Theft Prevention
2009 NOV 3 ... property and the arrests of more than 3,200 suspects involved in auto theft rings, chop shops, carjackings and fraudulent car thefts, among other auto theft-related crimes. ...
Subject: H.E.A.T. Help Eliminate Auto Thefts
Price: $3.00
*
Millennium Initiates Phase II Trial for Diffuse Large B-Cell Lymphoma
2009 NOV 2 ... trial examining rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone (R-CHOP) with or without VELCADE® (bortezomib) for Injection for patients with a common ...
Subject: Millennium: The Takeda Oncology Company
Price: $3.00
*
New cancer findings from University of Toledo, Medical Department described
2009 NOV 16 ... increased expression of CCAAT/enhancer binding protein homologous transcription factor (CHOP; GADD153). These effects of cal-C are not mimicked by staurosporine, an inhibitor of PKC ...
Subject: Cancer
Price: $3.00
*
New data from Genentech, Inc. illuminate research in non-hodgkin lymphoma
2009 NOV 2 ... anti-CD79b-vcMMAE was significantly more effective than a standard-of-care regimen, R-CHOP (ie, rituximab with a single intravenous injection of 30 mg/kg cyclophosphamide, 2.475 ...
Subject: Non-Hodgkin Lymphoma
View Free
Daily News
Article
New diabetic cardiomyopathy research from J.C. Xu and co-researchers described
2009 NOV 16 ... and apoptosis was detected by CCAAT/enhancer-binding protein (C/EBP) homologous protein (CHOP) and cleaved caspase-3 and caspase-12. Cardiac apoptosis in the WT diabetic mice, but ...
Subject: Diabetic Cardiomyopathy
Price: $3.00
*
New life sciences findings from B. Intriago and co-researchers published
2009 NOV 16 ... for response assessment of mediastinal bulky non-Hodgkin lymphoma after completion of a CHOP therapy regimen. The F-18 FDG-PET/CT scan showed complete response regarding the ...
Subject: Life Sciences
Price: $3.00
*
New National Study of Crash-Involved Children Reaffirms Recommendations for Booster Seat Through Age 8
2009 NOV 3 ... years old," explains lead researcher Kristy Arbogast, Ph.D., Director of Engineering at CHOP's Center for Injury Research and Prevention. "Since then, usage rates among older kids ...
Subject: Pediatrics
Price: $3.00
*
Reports from H. Blasco and co-researchers add new data to research in non-hodgkin lymphoma
2009 NOV 2 ... basis." "received four courses of rituximab (375 mg/m(2)) associated with CHOP (cyclophosphamide, adriamycin, vincristine and prednisone) at 21-day intervals. Blood ...
Subject: Non-Hodgkin Lymphoma
Price: $3.00
*
Research in the area of large B-cell lymphoma prognosis reported from University of Bologna, Institute of Hematology and Medical Oncology
2009 NOV 23 ... poor-prognosis. Six cycles of cyclophosphamide, doxorubicin, vincristine, prednisone (CHOP) in combination with rituximab achieved best results in young patients with low-risk ...
Subject: Large B-Cell Lymphoma Prognosis
Price: $3.00
*
Research on B-cell lymphoma immunotherapy reported by P. Rajnics et al
2009 NOV 2 ... is no widely accepted consensus on its treatment. We demonstrate that the rituximab and CHOP (cyclophosphamide, doxorubicin, vincristine, and prednisone; R...
Subject: B-Cell Lymphoma Immunotherapy
Price: $3.00
*
Research results from Columbia University update knowledge of apoptosis
2009 NOV 17 ... to apoptosis are incompletely understood. Based on roles for C/EPB homologous protein (CHOP) and ER calcium release in apoptosis, we hypothesized that apoptosis involves the ...
Subject: Apoptosis
Price: $3.00
*
RUI Holiday Gift Card Purchases Keep Giving to Children's Hospital Foundations
2009 NOV 26 ... operates 56 award-winning restaurants in twelve states including 15 Kincaid's Fish, Chop, and Steakhouses; 9 Palomino's, 9 Stanford's, 9 Newport Bay and Newport Seafood ...
Subject: Restaurants Unlimited, Inc.
Price: $3.00
*
Scientists at National Institutes of Health publish research in proteomics
2009 NOV 16 ... mutants using site-directed mutagenesis. Receptors were expressed in Balb-3T3-cells or CHOP cells, and affinities were determined. NMB had 115-fold greater affinity for NMBR than ...
Subject: Proteomics
Price: $3.00
*
Scientists at University of British Columbia publish new data on large B-cell lymphoma prognosis
2009 NOV 23 ... be cured with rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone (R-CHOP). However, the outcome following secondary therapies remains poor," scientists in ...
Subject: Large B-Cell Lymphoma Prognosis
Price: $3.00
*
Studies by D. Ternant and co-authors describe new findings in lymphoma therapy
2009 NOV 9 ... chemotherapy [rituximab, cyclophosphamide, vincristine, adriamycin and prednisone (R-CHOP)] in 334 relapsed/resistant FL patients and a study that evaluated rituximab monotherapy ...
Subject: Lymphoma Therapy
Price: $3.00
*
Study data from Fukuoka University provide new insights into non-hodgkin lymphoma risk factors
2009 NOV 23 ... "Here, we reviewed all the patients with non-Hodgkin lymphoma who were treated with RTX-CHOP-like regimen (R-CHOP) to determine the risk of ...
Subject: Non-Hodgkin Lymphoma Risk Factors
Price: $3.00
*
Study shows MabThera maintenance treatment delays disease progression in patients with incurable lymphoma
2009 NOV 16 ... with CD20 positive diffuse large B cell non-Hodgkin's lymphoma in combination with CHOP (cyclophosphamide, doxorubicin, vincristine, prednisolone) chemotherapy • ...
Subject: Follicular Lymphoma
Price: $3.00
*
The Children's Hospital of Philadelphia Appoints New Chief Nursing Officer
2009 NOV 17 ... with Kathy Gorman please contact Ashley Moore at 267-426-6071 or moorea1@email.chop.edu. Keywords: Pediatric Nursing, Pediatrics, The Children's Hospital of ...
Subject: Pediatrics
Price: $3.00
*

Results 1 - 20      Next >




-----------------------
PR Login